MFDS — authorised 19 October 2016
- Marketing authorisation holder: ELI LILLY AND CO
- Status: likely_approved
🇰🇷 Lartruvo in South Korea
MFDS authorised Lartruvo on 19 October 2016
Marketing authorisation
Lartruvo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Lartruvo approved in South Korea?
Yes. MFDS authorised it on 19 October 2016.
Who is the marketing authorisation holder for Lartruvo in South Korea?
ELI LILLY AND CO holds the South Korean marketing authorisation.